Global Point-of-Care Testing (POCT) Market Research Report 2023

Publisher Name :
Date: 24-Jan-2023
No. of pages: 120
Inquire Before Buying

Point-of-care (POC) is defined as medical testing at or near the site of patient care. The driving notion behind POCT is to bring the test conveniently and immediately to the patient. This increases the likelihood that the patient, physician, and care team will receive the results quicker, which allows for immediate clinical management decisions to be made.

The global Point-Of-Care Testing (POCT) market was valued at US$ 25670 million in 2022 and is anticipated to reach US$ 48500 million by 2029, witnessing a CAGR of 9.4% during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.

In China, the key players of point-of-care testing (POCT) include Sinocare, Wondfo, Roche, Abbott, LifeScan, etc. The top five players hold a share about 48% of China market. In terms of product type, blood glucose testing is the largest segment, occupied for a share of 44%, and in terms of application, hospitals has a share about 58 percent.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Point-Of-Care Testing (POCT), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Point-Of-Care Testing (POCT).

The Point-Of-Care Testing (POCT) market size, estimations, and forecasts are provided in terms of sales volume (M Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Point-Of-Care Testing (POCT) market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Point-Of-Care Testing (POCT) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.

By Company

- Roche

- Abbott

- LifeScan

- Siemens Healthineers

- Danaher

- Ascensia

- BioMerieux

- ARKRAY

- Sinocare

- Wondfo

- Yuwell

- Runbio

- KHB

- Wuhan Easy Diagnosis

- J.H.Bio-Tec

- Getein Biotech

- ReLIA

- BIOUHAN

- Beijing Wantai BioPharm

- Hotgen

- Intec PRODUCT

- Shenzhen YHLO

- Kang Hua

Segment by Type

- Blood Glucose Testing

- Infectious Diseases Testing

- Cardiac Markers Testing

- Coagulation Testing

- Pregnancy and Fertility Testing

- Blood Gas/Electrolytes Testing

- Urinalysis Testing

- Others

Segment by Application

- Hospitals

- Clinic

- Laboratory

- Others

Consumption by Region

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - China Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Detailed analysis of Point-Of-Care Testing (POCT) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Sales, revenue of Point-Of-Care Testing (POCT) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 9: The main points and conclusions of the report.

Global Point-of-Care Testing (POCT) Market Research Report 2023

Table of Contents
1 Point-Of-Care Testing (POCT) Market Overview
1.1 Product Overview and Scope of Point-Of-Care Testing (POCT)
1.2 Point-Of-Care Testing (POCT) Segment by Type
1.2.1 Global Point-Of-Care Testing (POCT) Market Value Comparison by Type (2023-2029)
1.2.2 Blood Glucose Testing
1.2.3 Infectious Diseases Testing
1.2.4 Cardiac Markers Testing
1.2.5 Coagulation Testing
1.2.6 Pregnancy and Fertility Testing
1.2.7 Blood Gas/Electrolytes Testing
1.2.8 Urinalysis Testing
1.2.9 Others
1.3 Point-Of-Care Testing (POCT) Segment by Application
1.3.1 Global Point-Of-Care Testing (POCT) Market Value by Application: (2023-2029)
1.3.2 Hospitals
1.3.3 Clinic
1.3.4 Laboratory
1.3.5 Others
1.4 Global Point-Of-Care Testing (POCT) Market Size Estimates and Forecasts
1.4.1 Global Point-Of-Care Testing (POCT) Revenue 2018-2029
1.4.2 Global Point-Of-Care Testing (POCT) Sales 2018-2029
1.4.3 Global Point-Of-Care Testing (POCT) Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Point-Of-Care Testing (POCT) Market Competition by Manufacturers
2.1 Global Point-Of-Care Testing (POCT) Sales Market Share by Manufacturers (2018-2023)
2.2 Global Point-Of-Care Testing (POCT) Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Point-Of-Care Testing (POCT) Average Price by Manufacturers (2018-2023)
2.4 Global Point-Of-Care Testing (POCT) Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Point-Of-Care Testing (POCT), Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Point-Of-Care Testing (POCT), Product Type & Application
2.7 Point-Of-Care Testing (POCT) Market Competitive Situation and Trends
2.7.1 Point-Of-Care Testing (POCT) Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Point-Of-Care Testing (POCT) Players Market Share by Revenue
2.7.3 Global Point-Of-Care Testing (POCT) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Point-Of-Care Testing (POCT) Retrospective Market Scenario by Region
3.1 Global Point-Of-Care Testing (POCT) Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Point-Of-Care Testing (POCT) Global Point-Of-Care Testing (POCT) Sales by Region: 2018-2029
3.2.1 Global Point-Of-Care Testing (POCT) Sales by Region: 2018-2023
3.2.2 Global Point-Of-Care Testing (POCT) Sales by Region: 2024-2029
3.3 Global Point-Of-Care Testing (POCT) Global Point-Of-Care Testing (POCT) Revenue by Region: 2018-2029
3.3.1 Global Point-Of-Care Testing (POCT) Revenue by Region: 2018-2023
3.3.2 Global Point-Of-Care Testing (POCT) Revenue by Region: 2024-2029
3.4 North America Point-Of-Care Testing (POCT) Market Facts & Figures by Country
3.4.1 North America Point-Of-Care Testing (POCT) Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Point-Of-Care Testing (POCT) Sales by Country (2018-2029)
3.4.3 North America Point-Of-Care Testing (POCT) Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Point-Of-Care Testing (POCT) Market Facts & Figures by Country
3.5.1 Europe Point-Of-Care Testing (POCT) Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Point-Of-Care Testing (POCT) Sales by Country (2018-2029)
3.5.3 Europe Point-Of-Care Testing (POCT) Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Point-Of-Care Testing (POCT) Market Facts & Figures by Country
3.6.1 Asia Pacific Point-Of-Care Testing (POCT) Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Point-Of-Care Testing (POCT) Sales by Country (2018-2029)
3.6.3 Asia Pacific Point-Of-Care Testing (POCT) Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Point-Of-Care Testing (POCT) Market Facts & Figures by Country
3.7.1 Latin America Point-Of-Care Testing (POCT) Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Point-Of-Care Testing (POCT) Sales by Country (2018-2029)
3.7.3 Latin America Point-Of-Care Testing (POCT) Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Point-Of-Care Testing (POCT) Market Facts & Figures by Country
3.8.1 Middle East and Africa Point-Of-Care Testing (POCT) Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Point-Of-Care Testing (POCT) Sales by Country (2018-2029)
3.8.3 Middle East and Africa Point-Of-Care Testing (POCT) Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Point-Of-Care Testing (POCT) Sales by Type (2018-2029)
4.1.1 Global Point-Of-Care Testing (POCT) Sales by Type (2018-2023)
4.1.2 Global Point-Of-Care Testing (POCT) Sales by Type (2024-2029)
4.1.3 Global Point-Of-Care Testing (POCT) Sales Market Share by Type (2018-2029)
4.2 Global Point-Of-Care Testing (POCT) Revenue by Type (2018-2029)
4.2.1 Global Point-Of-Care Testing (POCT) Revenue by Type (2018-2023)
4.2.2 Global Point-Of-Care Testing (POCT) Revenue by Type (2024-2029)
4.2.3 Global Point-Of-Care Testing (POCT) Revenue Market Share by Type (2018-2029)
4.3 Global Point-Of-Care Testing (POCT) Price by Type (2018-2029)
5 Segment by Application
5.1 Global Point-Of-Care Testing (POCT) Sales by Application (2018-2029)
5.1.1 Global Point-Of-Care Testing (POCT) Sales by Application (2018-2023)
5.1.2 Global Point-Of-Care Testing (POCT) Sales by Application (2024-2029)
5.1.3 Global Point-Of-Care Testing (POCT) Sales Market Share by Application (2018-2029)
5.2 Global Point-Of-Care Testing (POCT) Revenue by Application (2018-2029)
5.2.1 Global Point-Of-Care Testing (POCT) Revenue by Application (2018-2023)
5.2.2 Global Point-Of-Care Testing (POCT) Revenue by Application (2024-2029)
5.2.3 Global Point-Of-Care Testing (POCT) Revenue Market Share by Application (2018-2029)
5.3 Global Point-Of-Care Testing (POCT) Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Roche
6.1.1 Roche Corporation Information
6.1.2 Roche Description and Business Overview
6.1.3 Roche Point-Of-Care Testing (POCT) Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Roche Point-Of-Care Testing (POCT) Product Portfolio
6.1.5 Roche Recent Developments/Updates
6.2 Abbott
6.2.1 Abbott Corporation Information
6.2.2 Abbott Description and Business Overview
6.2.3 Abbott Point-Of-Care Testing (POCT) Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Abbott Point-Of-Care Testing (POCT) Product Portfolio
6.2.5 Abbott Recent Developments/Updates
6.3 LifeScan
6.3.1 LifeScan Corporation Information
6.3.2 LifeScan Description and Business Overview
6.3.3 LifeScan Point-Of-Care Testing (POCT) Sales, Revenue and Gross Margin (2018-2023)
6.3.4 LifeScan Point-Of-Care Testing (POCT) Product Portfolio
6.3.5 LifeScan Recent Developments/Updates
6.4 Siemens Healthineers
6.4.1 Siemens Healthineers Corporation Information
6.4.2 Siemens Healthineers Description and Business Overview
6.4.3 Siemens Healthineers Point-Of-Care Testing (POCT) Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Siemens Healthineers Point-Of-Care Testing (POCT) Product Portfolio
6.4.5 Siemens Healthineers Recent Developments/Updates
6.5 Danaher
6.5.1 Danaher Corporation Information
6.5.2 Danaher Description and Business Overview
6.5.3 Danaher Point-Of-Care Testing (POCT) Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Danaher Point-Of-Care Testing (POCT) Product Portfolio
6.5.5 Danaher Recent Developments/Updates
6.6 Ascensia
6.6.1 Ascensia Corporation Information
6.6.2 Ascensia Description and Business Overview
6.6.3 Ascensia Point-Of-Care Testing (POCT) Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Ascensia Point-Of-Care Testing (POCT) Product Portfolio
6.6.5 Ascensia Recent Developments/Updates
6.7 BioMerieux
6.6.1 BioMerieux Corporation Information
6.6.2 BioMerieux Description and Business Overview
6.6.3 BioMerieux Point-Of-Care Testing (POCT) Sales, Revenue and Gross Margin (2018-2023)
6.4.4 BioMerieux Point-Of-Care Testing (POCT) Product Portfolio
6.7.5 BioMerieux Recent Developments/Updates
6.8 ARKRAY
6.8.1 ARKRAY Corporation Information
6.8.2 ARKRAY Description and Business Overview
6.8.3 ARKRAY Point-Of-Care Testing (POCT) Sales, Revenue and Gross Margin (2018-2023)
6.8.4 ARKRAY Point-Of-Care Testing (POCT) Product Portfolio
6.8.5 ARKRAY Recent Developments/Updates
6.9 Sinocare
6.9.1 Sinocare Corporation Information
6.9.2 Sinocare Description and Business Overview
6.9.3 Sinocare Point-Of-Care Testing (POCT) Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Sinocare Point-Of-Care Testing (POCT) Product Portfolio
6.9.5 Sinocare Recent Developments/Updates
6.10 Wondfo
6.10.1 Wondfo Corporation Information
6.10.2 Wondfo Description and Business Overview
6.10.3 Wondfo Point-Of-Care Testing (POCT) Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Wondfo Point-Of-Care Testing (POCT) Product Portfolio
6.10.5 Wondfo Recent Developments/Updates
6.11 Yuwell
6.11.1 Yuwell Corporation Information
6.11.2 Yuwell Point-Of-Care Testing (POCT) Description and Business Overview
6.11.3 Yuwell Point-Of-Care Testing (POCT) Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Yuwell Point-Of-Care Testing (POCT) Product Portfolio
6.11.5 Yuwell Recent Developments/Updates
6.12 Runbio
6.12.1 Runbio Corporation Information
6.12.2 Runbio Point-Of-Care Testing (POCT) Description and Business Overview
6.12.3 Runbio Point-Of-Care Testing (POCT) Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Runbio Point-Of-Care Testing (POCT) Product Portfolio
6.12.5 Runbio Recent Developments/Updates
6.13 KHB
6.13.1 KHB Corporation Information
6.13.2 KHB Point-Of-Care Testing (POCT) Description and Business Overview
6.13.3 KHB Point-Of-Care Testing (POCT) Sales, Revenue and Gross Margin (2018-2023)
6.13.4 KHB Point-Of-Care Testing (POCT) Product Portfolio
6.13.5 KHB Recent Developments/Updates
6.14 Wuhan Easy Diagnosis
6.14.1 Wuhan Easy Diagnosis Corporation Information
6.14.2 Wuhan Easy Diagnosis Point-Of-Care Testing (POCT) Description and Business Overview
6.14.3 Wuhan Easy Diagnosis Point-Of-Care Testing (POCT) Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Wuhan Easy Diagnosis Point-Of-Care Testing (POCT) Product Portfolio
6.14.5 Wuhan Easy Diagnosis Recent Developments/Updates
6.15 J.H.Bio-Tec
6.15.1 J.H.Bio-Tec Corporation Information
6.15.2 J.H.Bio-Tec Point-Of-Care Testing (POCT) Description and Business Overview
6.15.3 J.H.Bio-Tec Point-Of-Care Testing (POCT) Sales, Revenue and Gross Margin (2018-2023)
6.15.4 J.H.Bio-Tec Point-Of-Care Testing (POCT) Product Portfolio
6.15.5 J.H.Bio-Tec Recent Developments/Updates
6.16 Getein Biotech
6.16.1 Getein Biotech Corporation Information
6.16.2 Getein Biotech Point-Of-Care Testing (POCT) Description and Business Overview
6.16.3 Getein Biotech Point-Of-Care Testing (POCT) Sales, Revenue and Gross Margin (2018-2023)
6.16.4 Getein Biotech Point-Of-Care Testing (POCT) Product Portfolio
6.16.5 Getein Biotech Recent Developments/Updates
6.17 ReLIA
6.17.1 ReLIA Corporation Information
6.17.2 ReLIA Point-Of-Care Testing (POCT) Description and Business Overview
6.17.3 ReLIA Point-Of-Care Testing (POCT) Sales, Revenue and Gross Margin (2018-2023)
6.17.4 ReLIA Point-Of-Care Testing (POCT) Product Portfolio
6.17.5 ReLIA Recent Developments/Updates
6.18 BIOUHAN
6.18.1 BIOUHAN Corporation Information
6.18.2 BIOUHAN Point-Of-Care Testing (POCT) Description and Business Overview
6.18.3 BIOUHAN Point-Of-Care Testing (POCT) Sales, Revenue and Gross Margin (2018-2023)
6.18.4 BIOUHAN Point-Of-Care Testing (POCT) Product Portfolio
6.18.5 BIOUHAN Recent Developments/Updates
6.19 Beijing Wantai BioPharm
6.19.1 Beijing Wantai BioPharm Corporation Information
6.19.2 Beijing Wantai BioPharm Point-Of-Care Testing (POCT) Description and Business Overview
6.19.3 Beijing Wantai BioPharm Point-Of-Care Testing (POCT) Sales, Revenue and Gross Margin (2018-2023)
6.19.4 Beijing Wantai BioPharm Point-Of-Care Testing (POCT) Product Portfolio
6.19.5 Beijing Wantai BioPharm Recent Developments/Updates
6.20 Hotgen
6.20.1 Hotgen Corporation Information
6.20.2 Hotgen Point-Of-Care Testing (POCT) Description and Business Overview
6.20.3 Hotgen Point-Of-Care Testing (POCT) Sales, Revenue and Gross Margin (2018-2023)
6.20.4 Hotgen Point-Of-Care Testing (POCT) Product Portfolio
6.20.5 Hotgen Recent Developments/Updates
6.21 Intec PRODUCT
6.21.1 Intec PRODUCT Corporation Information
6.21.2 Intec PRODUCT Point-Of-Care Testing (POCT) Description and Business Overview
6.21.3 Intec PRODUCT Point-Of-Care Testing (POCT) Sales, Revenue and Gross Margin (2018-2023)
6.21.4 Intec PRODUCT Point-Of-Care Testing (POCT) Product Portfolio
6.21.5 Intec PRODUCT Recent Developments/Updates
6.22 Shenzhen YHLO
6.22.1 Shenzhen YHLO Corporation Information
6.22.2 Shenzhen YHLO Point-Of-Care Testing (POCT) Description and Business Overview
6.22.3 Shenzhen YHLO Point-Of-Care Testing (POCT) Sales, Revenue and Gross Margin (2018-2023)
6.22.4 Shenzhen YHLO Point-Of-Care Testing (POCT) Product Portfolio
6.22.5 Shenzhen YHLO Recent Developments/Updates
6.23 Kang Hua
6.23.1 Kang Hua Corporation Information
6.23.2 Kang Hua Point-Of-Care Testing (POCT) Description and Business Overview
6.23.3 Kang Hua Point-Of-Care Testing (POCT) Sales, Revenue and Gross Margin (2018-2023)
6.23.4 Kang Hua Point-Of-Care Testing (POCT) Product Portfolio
6.23.5 Kang Hua Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Point-Of-Care Testing (POCT) Industry Chain Analysis
7.2 Point-Of-Care Testing (POCT) Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Point-Of-Care Testing (POCT) Production Mode & Process
7.4 Point-Of-Care Testing (POCT) Sales and Marketing
7.4.1 Point-Of-Care Testing (POCT) Sales Channels
7.4.2 Point-Of-Care Testing (POCT) Distributors
7.5 Point-Of-Care Testing (POCT) Customers
8 Point-Of-Care Testing (POCT) Market Dynamics
8.1 Point-Of-Care Testing (POCT) Industry Trends
8.2 Point-Of-Care Testing (POCT) Market Drivers
8.3 Point-Of-Care Testing (POCT) Market Challenges
8.4 Point-Of-Care Testing (POCT) Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Point-Of-Care Testing (POCT) Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Point-Of-Care Testing (POCT) Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Point-Of-Care Testing (POCT) Market Competitive Situation by Manufacturers in 2022
Table 4. Global Point-Of-Care Testing (POCT) Sales (M Units) of Key Manufacturers (2018-2023)
Table 5. Global Point-Of-Care Testing (POCT) Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Point-Of-Care Testing (POCT) Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Point-Of-Care Testing (POCT) Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Point-Of-Care Testing (POCT) Average Price (US$/K Units) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Point-Of-Care Testing (POCT), Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Point-Of-Care Testing (POCT), Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Point-Of-Care Testing (POCT), Product Type & Application
Table 12. Global Key Manufacturers of Point-Of-Care Testing (POCT), Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Point-Of-Care Testing (POCT) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Point-Of-Care Testing (POCT) as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Point-Of-Care Testing (POCT) Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Point-Of-Care Testing (POCT) Sales by Region (2018-2023) & (M Units)
Table 18. Global Point-Of-Care Testing (POCT) Sales Market Share by Region (2018-2023)
Table 19. Global Point-Of-Care Testing (POCT) Sales by Region (2024-2029) & (M Units)
Table 20. Global Point-Of-Care Testing (POCT) Sales Market Share by Region (2024-2029)
Table 21. Global Point-Of-Care Testing (POCT) Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Point-Of-Care Testing (POCT) Revenue Market Share by Region (2018-2023)
Table 23. Global Point-Of-Care Testing (POCT) Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Point-Of-Care Testing (POCT) Revenue Market Share by Region (2024-2029)
Table 25. North America Point-Of-Care Testing (POCT) Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Point-Of-Care Testing (POCT) Sales by Country (2018-2023) & (M Units)
Table 27. North America Point-Of-Care Testing (POCT) Sales by Country (2024-2029) & (M Units)
Table 28. North America Point-Of-Care Testing (POCT) Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Point-Of-Care Testing (POCT) Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Point-Of-Care Testing (POCT) Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Point-Of-Care Testing (POCT) Sales by Country (2018-2023) & (M Units)
Table 32. Europe Point-Of-Care Testing (POCT) Sales by Country (2024-2029) & (M Units)
Table 33. Europe Point-Of-Care Testing (POCT) Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Point-Of-Care Testing (POCT) Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Point-Of-Care Testing (POCT) Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Point-Of-Care Testing (POCT) Sales by Region (2018-2023) & (M Units)
Table 37. Asia Pacific Point-Of-Care Testing (POCT) Sales by Region (2024-2029) & (M Units)
Table 38. Asia Pacific Point-Of-Care Testing (POCT) Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Point-Of-Care Testing (POCT) Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Point-Of-Care Testing (POCT) Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Point-Of-Care Testing (POCT) Sales by Country (2018-2023) & (M Units)
Table 42. Latin America Point-Of-Care Testing (POCT) Sales by Country (2024-2029) & (M Units)
Table 43. Latin America Point-Of-Care Testing (POCT) Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Point-Of-Care Testing (POCT) Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Point-Of-Care Testing (POCT) Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Point-Of-Care Testing (POCT) Sales by Country (2018-2023) & (M Units)
Table 47. Middle East & Africa Point-Of-Care Testing (POCT) Sales by Country (2024-2029) & (M Units)
Table 48. Middle East & Africa Point-Of-Care Testing (POCT) Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Point-Of-Care Testing (POCT) Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Point-Of-Care Testing (POCT) Sales (M Units) by Type (2018-2023)
Table 51. Global Point-Of-Care Testing (POCT) Sales (M Units) by Type (2024-2029)
Table 52. Global Point-Of-Care Testing (POCT) Sales Market Share by Type (2018-2023)
Table 53. Global Point-Of-Care Testing (POCT) Sales Market Share by Type (2024-2029)
Table 54. Global Point-Of-Care Testing (POCT) Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Point-Of-Care Testing (POCT) Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Point-Of-Care Testing (POCT) Revenue Market Share by Type (2018-2023)
Table 57. Global Point-Of-Care Testing (POCT) Revenue Market Share by Type (2024-2029)
Table 58. Global Point-Of-Care Testing (POCT) Price (US$/K Units) by Type (2018-2023)
Table 59. Global Point-Of-Care Testing (POCT) Price (US$/K Units) by Type (2024-2029)
Table 60. Global Point-Of-Care Testing (POCT) Sales (M Units) by Application (2018-2023)
Table 61. Global Point-Of-Care Testing (POCT) Sales (M Units) by Application (2024-2029)
Table 62. Global Point-Of-Care Testing (POCT) Sales Market Share by Application (2018-2023)
Table 63. Global Point-Of-Care Testing (POCT) Sales Market Share by Application (2024-2029)
Table 64. Global Point-Of-Care Testing (POCT) Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Point-Of-Care Testing (POCT) Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Point-Of-Care Testing (POCT) Revenue Market Share by Application (2018-2023)
Table 67. Global Point-Of-Care Testing (POCT) Revenue Market Share by Application (2024-2029)
Table 68. Global Point-Of-Care Testing (POCT) Price (US$/K Units) by Application (2018-2023)
Table 69. Global Point-Of-Care Testing (POCT) Price (US$/K Units) by Application (2024-2029)
Table 70. Roche Corporation Information
Table 71. Roche Description and Business Overview
Table 72. Roche Point-Of-Care Testing (POCT) Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2018-2023)
Table 73. Roche Point-Of-Care Testing (POCT) Product
Table 74. Roche Recent Developments/Updates
Table 75. Abbott Corporation Information
Table 76. Abbott Description and Business Overview
Table 77. Abbott Point-Of-Care Testing (POCT) Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2018-2023)
Table 78. Abbott Point-Of-Care Testing (POCT) Product
Table 79. Abbott Recent Developments/Updates
Table 80. LifeScan Corporation Information
Table 81. LifeScan Description and Business Overview
Table 82. LifeScan Point-Of-Care Testing (POCT) Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2018-2023)
Table 83. LifeScan Point-Of-Care Testing (POCT) Product
Table 84. LifeScan Recent Developments/Updates
Table 85. Siemens Healthineers Corporation Information
Table 86. Siemens Healthineers Description and Business Overview
Table 87. Siemens Healthineers Point-Of-Care Testing (POCT) Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2018-2023)
Table 88. Siemens Healthineers Point-Of-Care Testing (POCT) Product
Table 89. Siemens Healthineers Recent Developments/Updates
Table 90. Danaher Corporation Information
Table 91. Danaher Description and Business Overview
Table 92. Danaher Point-Of-Care Testing (POCT) Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2018-2023)
Table 93. Danaher Point-Of-Care Testing (POCT) Product
Table 94. Danaher Recent Developments/Updates
Table 95. Ascensia Corporation Information
Table 96. Ascensia Description and Business Overview
Table 97. Ascensia Point-Of-Care Testing (POCT) Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2018-2023)
Table 98. Ascensia Point-Of-Care Testing (POCT) Product
Table 99. Ascensia Recent Developments/Updates
Table 100. BioMerieux Corporation Information
Table 101. BioMerieux Description and Business Overview
Table 102. BioMerieux Point-Of-Care Testing (POCT) Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2018-2023)
Table 103. BioMerieux Point-Of-Care Testing (POCT) Product
Table 104. BioMerieux Recent Developments/Updates
Table 105. ARKRAY Corporation Information
Table 106. ARKRAY Description and Business Overview
Table 107. ARKRAY Point-Of-Care Testing (POCT) Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2018-2023)
Table 108. ARKRAY Point-Of-Care Testing (POCT) Product
Table 109. ARKRAY Recent Developments/Updates
Table 110. Sinocare Corporation Information
Table 111. Sinocare Description and Business Overview
Table 112. Sinocare Point-Of-Care Testing (POCT) Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2018-2023)
Table 113. Sinocare Point-Of-Care Testing (POCT) Product
Table 114. Sinocare Recent Developments/Updates
Table 115. Wondfo Corporation Information
Table 116. Wondfo Description and Business Overview
Table 117. Wondfo Point-Of-Care Testing (POCT) Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2018-2023)
Table 118. Wondfo Point-Of-Care Testing (POCT) Product
Table 119. Wondfo Recent Developments/Updates
Table 120. Yuwell Corporation Information
Table 121. Yuwell Description and Business Overview
Table 122. Yuwell Point-Of-Care Testing (POCT) Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2018-2023)
Table 123. Yuwell Point-Of-Care Testing (POCT) Product
Table 124. Yuwell Recent Developments/Updates
Table 125. Runbio Corporation Information
Table 126. Runbio Description and Business Overview
Table 127. Runbio Point-Of-Care Testing (POCT) Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2018-2023)
Table 128. Runbio Point-Of-Care Testing (POCT) Product
Table 129. Runbio Recent Developments/Updates
Table 130. KHB Corporation Information
Table 131. KHB Description and Business Overview
Table 132. KHB Point-Of-Care Testing (POCT) Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2018-2023)
Table 133. KHB Point-Of-Care Testing (POCT) Product
Table 134. KHB Recent Developments/Updates
Table 135. Wuhan Easy Diagnosis Corporation Information
Table 136. Wuhan Easy Diagnosis Description and Business Overview
Table 137. Wuhan Easy Diagnosis Point-Of-Care Testing (POCT) Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2018-2023)
Table 138. Wuhan Easy Diagnosis Point-Of-Care Testing (POCT) Product
Table 139. Wuhan Easy Diagnosis Recent Developments/Updates
Table 140. J.H.Bio-Tec Corporation Information
Table 141. J.H.Bio-Tec Description and Business Overview
Table 142. J.H.Bio-Tec Point-Of-Care Testing (POCT) Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2018-2023)
Table 143. J.H.Bio-Tec Point-Of-Care Testing (POCT) Product
Table 144. J.H.Bio-Tec Recent Developments/Updates
Table 145. Getein Biotech Corporation Information
Table 146. Getein Biotech Description and Business Overview
Table 147. Getein Biotech Point-Of-Care Testing (POCT) Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2018-2023)
Table 148. Getein Biotech Point-Of-Care Testing (POCT) Product
Table 149. Getein Biotech Recent Developments/Updates
Table 150. ReLIA Corporation Information
Table 151. ReLIA Description and Business Overview
Table 152. ReLIA Point-Of-Care Testing (POCT) Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2018-2023)
Table 153. ReLIA Point-Of-Care Testing (POCT) Product
Table 154. ReLIA Recent Developments/Updates
Table 155. BIOUHAN Corporation Information
Table 156. BIOUHAN Description and Business Overview
Table 157. BIOUHAN Point-Of-Care Testing (POCT) Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2018-2023)
Table 158. BIOUHAN Point-Of-Care Testing (POCT) Product
Table 159. BIOUHAN Recent Developments/Updates
Table 160. Beijing Wantai BioPharm Corporation Information
Table 161. Beijing Wantai BioPharm Description and Business Overview
Table 162. Beijing Wantai BioPharm Point-Of-Care Testing (POCT) Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2018-2023)
Table 163. Beijing Wantai BioPharm Point-Of-Care Testing (POCT) Product
Table 164. Beijing Wantai BioPharm Recent Developments/Updates
Table 165. Hotgen Corporation Information
Table 166. Hotgen Description and Business Overview
Table 167. Hotgen Point-Of-Care Testing (POCT) Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2018-2023)
Table 168. Hotgen Point-Of-Care Testing (POCT) Product
Table 169. Hotgen Recent Developments/Updates
Table 170. Intec PRODUCT Corporation Information
Table 171. Intec PRODUCT Description and Business Overview
Table 172. Intec PRODUCT Point-Of-Care Testing (POCT) Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2018-2023)
Table 173. Intec PRODUCT Point-Of-Care Testing (POCT) Product
Table 174. Intec PRODUCT Recent Developments/Updates
Table 175. Shenzhen YHLO Corporation Information
Table 176. Shenzhen YHLO Description and Business Overview
Table 177. Shenzhen YHLO Point-Of-Care Testing (POCT) Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2018-2023)
Table 178. Shenzhen YHLO Point-Of-Care Testing (POCT) Product
Table 179. Shenzhen YHLO Recent Developments/Updates
Table 180. Kang Hua Corporation Information
Table 181. Kang Hua Description and Business Overview
Table 182. Kang Hua Point-Of-Care Testing (POCT) Sales (M Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2018-2023)
Table 183. Kang Hua Point-Of-Care Testing (POCT) Product
Table 184. Kang Hua Recent Developments/Updates
Table 185. Key Raw Materials Lists
Table 186. Raw Materials Key Suppliers Lists
Table 187. Point-Of-Care Testing (POCT) Distributors List
Table 188. Point-Of-Care Testing (POCT) Customers List
Table 189. Point-Of-Care Testing (POCT) Market Trends
Table 190. Point-Of-Care Testing (POCT) Market Drivers
Table 191. Point-Of-Care Testing (POCT) Market Challenges
Table 192. Point-Of-Care Testing (POCT) Market Restraints
Table 193. Research Programs/Design for This Report
Table 194. Key Data Information from Secondary Sources
Table 195. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Point-Of-Care Testing (POC
  • Global Influenza Diagnostics Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 85
    Influenza is an infectious disease and affects The upper respiratory tract in humans. The disease is common in children and elderly population (aged 65 years and above). The disease has a huge impact on Public Company health. Influenza A virus poses a greater risk as compared to The influenza B virus. The B virus is responsible for 20% to 25% of infections globally. Proper collection, storage and transport of respiratory specimens are The essential first step for laboratory detection of influenz......
  • Global Tuberculosis (TB) Diagnostics Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 107
    According to our LPI (LP Information) latest study, the global Tuberculosis (TB) Diagnostics market size was valued at US$ 2572.8 million in 2023. With growing demand in downstream market, the Tuberculosis (TB) Diagnostics is forecast to a readjusted size of US$ 3540.9 million by 2030 with a CAGR of 4.7% during review period. The research report highlights the growth potential of the global Tuberculosis (TB) Diagnostics market. Tuberculosis (TB) Diagnostics are expected to show stable gr......
  • Global POC Diagnostics Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 128
    According to our LPI (LP Information) latest study, the global POC Diagnostics market size was valued at US$ 25110 million in 2023. With growing demand in downstream market, the POC Diagnostics is forecast to a readjusted size of US$ 48170 million by 2030 with a CAGR of 9.8% during review period. The research report highlights the growth potential of the global POC Diagnostics market. POC Diagnostics are expected to show stable growth in the future market. However, product differentiatio......
  • Global Allergy Diagnostics Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 109
    According to our LPI (LP Information) latest study, the global Allergy Diagnostics market size was valued at US$ 5070.7 million in 2023. With growing demand in downstream market, the Allergy Diagnostics is forecast to a readjusted size of US$ 10550 million by 2030 with a CAGR of 11.0% during review period. The research report highlights the growth potential of the global Allergy Diagnostics market. Allergy Diagnostics are expected to show stable growth in the future market. However, prod......
  • Global Influenza Diagnostics Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 100
    According to our LPI (LP Information) latest study, the global Influenza Diagnostics market size was valued at US$ 2284.7 million in 2023. With growing demand in downstream market, the Influenza Diagnostics is forecast to a readjusted size of US$ 3558.7 million by 2030 with a CAGR of 6.5% during review period. The research report highlights the growth potential of the global Influenza Diagnostics market. Influenza Diagnostics are expected to show stable growth in the future market. Howev......
  • Global Tuberculosis (TB) Diagnostics Market 2024 by Company, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 112
    According to our (Global Info Research) latest study, the global Tuberculosis (TB) Diagnostics market size was valued at USD 2706.1 million in 2023 and is forecast to a readjusted size of USD 3635.2 million by 2030 with a CAGR of 4.3% during review period. Tuberculosis (TB) is an infectious disease usually caused by the bacterium Mycobacterium tuberculosis (MTB). Tuberculosis generally affects the lungs, but can also affect other parts of the body. Most infections do not have symptoms, i......
  • Global Influenza Diagnostics Market 2024 by Company, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 111
    According to our (Global Info Research) latest study, the global Influenza Diagnostics market size was valued at USD 2403.1 million in 2023 and is forecast to a readjusted size of USD 3620.3 million by 2030 with a CAGR of 6.0% during review period. Influenza is an infectious disease and affects the upper respiratory tract in humans. The disease is common in children and elderly population (aged 65 years and above). The disease has a huge impact on Public Company health. Influenza A virus......
  • Global Point-of-Care Diagnostics Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 12-Dec-2023        Price: US 3380 Onwards        Pages: 122
    Market Overview of Global Point-of-Care Diagnostics market: According to our latest research, the global Point-of-Care Diagnostics market looks promising in the next 5 years. As of 2022, the global Point-of-Care Diagnostics market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the glo......
  • Global Viral Disease Diagnosis Professional Survey Report 2023, Forecast to 2028
    Published: 27-Nov-2023        Price: US 3280 Onwards        Pages: 105
    They have been used as an alternative method of diagnosing viral diseases. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product launches, and market capital flows are compared acr......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs